What is it about?
The present study aimed at the development of a pH-sensitive liposome to co-deliver drug and siRNA to tumor region. Driven by the electrostatic interaction, the pH-sensitive material, carboxymethyl chitosan (CMCS), was coated onto the surface of the cationic liposome (CL) pre-loaded with sorafenib (Sf) and siRNA (Si). In vitro and in vivo experiments were evaluated in HepG2 cells and the H22 cells-bearing Kunming mice model.
Featured Image
Why is it important?
In current experimental conditions, this liposomal formulation did not show significant toxicity both in vitro and in vivo. Therefore, co-delivering Sf with siRNA by CMCS-SiSf-CL might provide a promising approach for tumor therapy.
Read the Original
This page is a summary of: pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery, International Journal of Nanomedicine, October 2015, Dove Medical Press,
DOI: 10.2147/ijn.s90524.
You can read the full text:
Contributors
The following have contributed to this page







